[Hong Kong, 4 March 2016]  Hong Kong Applied Science and Technology Research Institute Company Limited (ASTRI) has announced the appointment of Mr Andy Liu, Vice Chairman of Hong Kong Biotechnology Organization, to the ASTRI Board for a term of two years with effect from 1 March 2016.

Mr Andy Liu has served as President of Asia Pacific and China for IMS Health, a TPG private equity portfolio company focusing on big data healthcare.   Mr Liu’s area of focus is commercialisation and M&A.  He has extensive experience in healthcare big data and healthcare technologies.

Furthermore, commencing 1 March 2016, three serving Directors of ASTRI, namely Mr Cheng Cheuk-wing, Prof Ching Pak-chung and Mr  Ha Yung-kuen have also been re-appointed for another two-year term.

Related News

New Directors appointed to ASTRI Board

[Hong Kong, 19 October 2018] Hong Kong Applied Science and Technology Research Institute Company Lim ...

Fujian delegation led by Provincial Party Secretary Mr Yu Weiguo visits ASTRI

Fujian Provincial Party Secretary Mr Yu Weiguo, joined by Mr Nicholas Yang Wei-hsiung, Secretary for ...

ASTRI’s R&D expert shares insights on Digital Transformation at 2018 IBM AI Solution Summit

Dr T John Koo, Director of Cyber-Physical Systems of ASTRI, was invited to speak on the topic 'Enabl ...

ASTRI demonstrates its latest technologies at PT EXPO China 2018 in Beijing

The Hong Kong Applied Science and Technology Research Institute (ASTRI) is showcasing its latest tec ...

Mr Wang Zhigang, national Minister for Science and Technology, visits ASTRI

[Hong Kong, 21 September 2018] Mr Wang Zhigang, Minister for Science and Technology of the People’s ...